OMIC USA Inc.

July 2, 2012 — With the ongoing expansion of the Food Safety Modernization Act (FSMA) there is an increasing number of foods and commodities being tested by the FDA at the time of import. Illegal residues are often detected through routine sampling, which leads to a refusal of entry for that shipment and automatic detention going forward. Unfortunately for importers, this Detention Without Physical Examination or DWPE (formerly referred to as FDA Automatic Detention) can be a worrisome and confusing situation.

In the face of this ongoing challenge, OMIC USA Inc. (www.omicusa.com) is pleased to announce its capability to test samples and submit analytical packages towards clearance of FDA detention. With a current arsenal of instruments, integral quality system, and highly qualified scientists, we have already successfully submitted a number of packages on behalf of clients who were dealing with the specific problems associated with an FDA Detention Notice.

From start to finish, OMIC USA Inc. handles all of the complicated details. We offer 1) a nationwide network of sampling agents who collect and document samples according to very specific requirements, 2) ISO 17025 accredited analysis for the substance in question, and 3) the experience required to compile the report that will serve as the client’s response to the FDA notice. Please contact us as soon as possible following receipt of an FDA notice of detention in order to receive assistance in navigating the process and avoid any potential delays.

March 29, 2012 — The Korea Food and Drug Administration (KFDA) has accredited analytical laboratory OMIC USA Inc. in the field of genetically modified organism (GMO) testing as per a communiqué received from the KFDA on March 29, 2012. This certification is the culmination of a two-year approval process that began in 2009 and included two on-site audits performed by the KFDA. OMIC USA Inc. now boasts the ability to issue KFDA-accredited GMO certificates to companies and individuals exporting food and feed products to the Republic of Korea.

OMIC USA Inc. in 1999 became the first private U.S. laboratory to be approved by the Korean Food & Drug Administration to test for pesticide residues; this scope was broadened in 2008 to include testing and certification in the fields of nutrition, food supplements, and vitamins.

The benefit of OMIC USA’s new scope of accreditation is twofold: 1) U.S. exporters can now rest assured that their cargo will be accepted at South Korean ports of entry because KFDA standards have been met, and 2) Korean consumers will have peace of mind knowing that their food products are safe and compliant with Korean GMO labeling standards.

The DNA/GMO laboratory at OMIC USA operates under ISO 17025 quality management systems in GMO testing under the leadership of Dr. Chong Singsit, Ph.D., a transgenic research and GMO testing veteran with twenty years of experience. As an additional asset OMIC USA has a Korean analytical chemist, Seong Rai Cho, M.S., who is a native speaker and has trained in a KFDA-affiliated laboratory in Seoul, South Korea.